The selective A2AR agonist, CGS21680 can inhibit the EAE progression.
Treatment with CGS21680 significantly suppressed specific lymphocyte proliferation.
Treatment with CGS21680 reduced infiltration of CD4+ T lymphocyte in nerve tissue.
Treatment with CGS21680 reduced the expression of inflammatory cytokines.
CGS21680 can increase the intracellular calcium concentration in lymphocytes.